BTG plc (LON:BTG – Get Free Report) shares traded up 0.1% on Thursday . The company traded as high as GBX 840 ($10.60) and last traded at GBX 840 ($10.60). 271,742 shares changed hands during trading, a decline of 72% from the average session volume of 960,389 shares. The stock had previously closed at GBX 839 ($10.59).
BTG Stock Performance
The company has a 50-day moving average of GBX 840 and a 200-day moving average of GBX 840. The stock has a market capitalization of £3.26 billion and a price-to-earnings ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Articles
- Five stocks we like better than BTG
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The How And Why of Investing in Oil Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
